| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
John H. Lee last filed a Form 4 in May 2024, as Director at VINC. John H. Lee's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 799 shares of VINC. Net of sales, the VINC filings show accumulation of 799 shares.
John H. Lee has 6 Form 4 filings on record from December 2020 to May 2024, all as Director at Vincerx Pharma (VINC), 2020–2024.
The 6 reported transactions were 5 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 799 shares of VINC at an average $12.71 on June 29, 2021, about $10K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | VINC Vincerx Pharma, Inc. | Director | Buy | 799 | $12.72 | $10,159.29 | New |